InsiderSignal.AI

InsiderSignal.ai

PRCT - Procept Biorobotics Corp

Insider Purchase by Moll Frederic H (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Moll Frederic H, serving as Dir at Procept Biorobotics Corp (PRCT), purchased 20,000 shares at $39.26 per share, for a total transaction value of $785,138.00. Following this transaction, Moll Frederic H now holds 863,159 shares of PRCT.

This purchase represents a 2.00% increase in Moll Frederic H's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 13, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, August 14, 2025, 1 day after the trade was made.

Procept Biorobotics Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Moll Frederic H

Dir

Frederic H. Moll, born in 1952, is a pioneering physician, entrepreneur, and medical robotics expert often called the 'father of robotic surgery.' He earned a B.A. from the University of California, Berkeley, an M.D. from the University of Washington, and an M.S. in business management from Stanford University[[2]](https://www.pumaventurecapital.com/fred-moll)[[4]](https://en.wikipedia.org/wiki/Frederic_Moll). Moll's career highlights include co-founding Intuitive Surgical in 1995, developing the da Vinci surgical system, and serving as its early leader until 2002[[2]](https://www.pumaventurecapital.com/fred-moll)[[3]](https://sondercapital.com/person/fred-moll/)[[4]](https://en.wikipedia.org/wiki/Frederic_Moll). He founded Hansen Medical (2002), Auris Health (2007, acquired by Johnson & Johnson in 2019, where he served as CEO and later Chief Development Officer until 2023), and is Founding Partner of Sonder Capital Management[[2]](https://www.pumaventurecapital.com/fred-moll)[[3]](https://sondercapital.com/person/fred-moll/). At Procept BioRobotics Corp (PRCT), he has been a director since August 2011 and Chair since March 2021, recently purchasing 20,000 shares on August 13, 2025, at $39.26 per share, bringing his direct ownership to 863,159 shares[[1]](https://www.ainvest.com/news/procept-biorobotics-director-moll-frederic-buys-20-000-shares-39-26-share-2508/)[[2]](https://www.pumaventurecapital.com/fred-moll)[[5]](https://www.nasdaq.com/market-activity/insiders/moll-frederic-h-425974). He currently serves on boards including Shockwave Medical, INSIGHTEC, and others[[2]](https://www.pumaventurecapital.com/fred-moll)[[3]](https://sondercapital.com/person/fred-moll/).

View full insider profile →

Trade Price

$39.26

Quantity

20,000

Total Value

$785,138.00

Shares Owned

863,159

Trade Date

Wednesday, August 13, 2025

193 days ago

SEC Filing Date

Thursday, August 14, 2025

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Procept Biorobotics Corp

Company Overview

No company information available
View news mentioning PRCT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/128026

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime